CN101204436B - Chinese patent medicine for curing hyperosteogeny in knee joint - Google Patents
Chinese patent medicine for curing hyperosteogeny in knee joint Download PDFInfo
- Publication number
- CN101204436B CN101204436B CN2007101152980A CN200710115298A CN101204436B CN 101204436 B CN101204436 B CN 101204436B CN 2007101152980 A CN2007101152980 A CN 2007101152980A CN 200710115298 A CN200710115298 A CN 200710115298A CN 101204436 B CN101204436 B CN 101204436B
- Authority
- CN
- China
- Prior art keywords
- grams
- medicine
- knee joint
- treatment
- chinese patent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an Chinese patent medicine used for treating gastric ulcer belonging to the field of traditional Chinese medicine.The oral combination of Chinese medicine used for treating gastric ulcer comprises olibanum, myrrh, scorpion, pangolin scale, suberect spatholobus, corydalis, salvia root, pyrola, malaytea scurfpea fruit and clematis root prepared as a certain weight account. The medicine is boiled in water, and one dose is divided into two shares per day for serving separately.Fifteen days is taken as one course. With the cooperation effect of the medicine, the medicine obtains an unexpected effect in the process of treating the irregular menstruation.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of knee joint hyperosteogeny, is a kind of Chinese patent medicine that is used for the treatment of knee joint hyperosteogeny specifically, belongs to the field of Chinese medicines.
Background technology
Bone matrix hyperplasia is to cause local joint, muscle, ligament moving obstacle with the sclerotin pathological proliferation, and the pain that occurs together is the disease of cardinal symptom.
The cardinal symptom of hyperosteogeny disease has crunch and pain when being the joint active movement, stair activity, slope or obvious especially when seat is stood when pushing patella, can have and press logical and the friction sense, patella periphery or joint space tenderness, sometimes the continent is amassed in knee joint swelling, and floating kneecap sense is arranged, sometimes fat pad hypertrophy under the kneecap, plump, sclerosis can be from the other lumps of touching of kneecap tendon.If plump synovium of joint, fat pad is stuck between articular surface when joint motion under disruptive meniscus episome or the kneecap, can produce the interlocking symptom.The quadriceps femoris spasm can appear in acute stage, and this amyotrophy of later stage is obviously limited during joint motion, frequent pain, and the joint edge deformation increases slightly.Last arthrodesis is in the curved attitude of semiflexion.
The reason that causes hyperosteogeny is a lot, and wherein modal is the hyperosteogeny that the skeleton degenerative change causes.This hyperosteogeny is relevant with the aging of human body, is the performance that Human Physiology changes.
Chinese medicinal formulae of the present invention is without any side effects, has avoided pain of postoperative that the doctor trained in Western medicine operative treatment brings.Efficiently solve drawback difficult point such as relapse rate height behind the operative therapy.The patient only need use this pharmaceutical treatment can contain the elimination symptom rapidly, and powerful relaxing muscles and tendons to promote blood circulation activates microcirculation, promotes local metabolic, breaks up to absorb alluvial calcification hypertrophy part, fundamentally solves hyperosteogeny, bony spur disease.
Summary of the invention
The object of the present invention is to provide a kind of Chinese patent medicine that is used for the treatment of knee joint hyperosteogeny, it is obvious to be used for the treatment of the knee hyperplasia effect.
Technical scheme of the present invention is: a kind of Chinese patent medicine that is used for the treatment of knee joint hyperosteogeny, make one day dosage by following raw material medicaments.
Prescription: Olibanum 10 grams, Myrrha 12 grams, Scorpio 10 grams, Squama Manis 10 grams, Caulis Spatholobi 15 grams, Rhizoma Corydalis 12 grams, Radix Salviae Miltiorrhizae 15 grams, Herba Pyrolae 15 grams, Fructus Psoraleae 10 grams, Radix Clematidis 10 grams.
Usage: decocting, 1 dose of every day, 2 sub-services.15 days courses of treatment.
Pharmacological action:
Olibanum: regulating qi and activating blood, analgesic therapy chases after poison.Control coagulation of QI-blood, trusted subordinate's pain, carbuncle pyogenic infections from tumour or sore, traumatic injury, dysmenorrhea, postnatal blood stasis twinge.
Myrrha: the blood blood stasis removing that looses, subduing swelling and relieving pain.Control and fall damage, incised wound, muscles and bones, all Tong ， of trusted subordinate mass in the abdomen, amenorrhea, ulcer sore pain.
Scorpio: dispel the wind relieving convulsion, collateral dredging, detoxifcation.Control infantile convulsion and take out and pluck, epilepsy, apoplexy, hemiplegia, migraine, rheumatic arthralgia, tetanus, the rubella skin ulcer is swollen.
Squama Manis: the routed carbuncle of detumescence, it is active to search wind, the stimulating milk secretion of stimulating the menstrual flow.Control carbuncle skin ulcer kind, anemofrigid-damp arthralgia, amenorrhea, galactostasis.
Caulis Spatholobi: blood circulation promoting and blood stasis dispelling, it is warm in nature, and bitter in the mouth, sweet is returned liver, kidney channel.Have enrich blood, invigorate blood circulation, the effect of collateral dredging.
Rhizoma Corydalis: promoting blood circulation to remove blood stasis, promoting the circulation of QI pain relieving.Be used for pain of each qi depression to blood stasis of whole body, dysmenorrhea, amenorrhea, lump in the abdomen, postpartum stagnation, injury from falling down, hernia is had a pain.
Radix Salviae Miltiorrhizae: blood circulation promoting and blood stasis dispelling, calming heart and tranquilizing mind, evacuation of pus, pain relieving.Control angina pectoris, menoxenia, metrorrhagia leukorrhagia, abdominal pain due to blood stasis, arthralgia, malignant boil toxic swelling.
Herba Pyrolae: tonify deficiency, kidney tonifying, expelling wind and removing dampness, promoting blood flow to regulate menstruation is controlled weak cough, over-strained hemoptysis, rheumatic arthritis, metrorrhagia, leucorrhea, traumatic hemorrhage.
Fructus Psoraleae: reinforcing the kidney and supporting YANG.Control the cold diarrhea of suffering from a deficiency of the kidney, the enuresis, spermatorrhea, frequent micturition, sexual impotence, chills and pain of the waist and kness, deficiency and coldness is breathed heavily and is coughed.
Radix Clematidis: wind-damp dispelling, the meridian dredging, expectorant saliva, the hypochondriac lump of loosing.Control gout, insensitive impediment, chills and pain of the waist and kness, beriberi, malaria ， lumps in the chest and abdomen, tetanus, tonsillitis, all a fishbone or other bone caught in the throat pharynxs.
After the present invention mixed said medicine, its drug effect synergism had been obtained remarkable result in the process of knee joint hyperosteogeny.
Model case is as follows:
Case one, Zhang Aiqi, woman, 56 years old, people from Shouguang City, Shandong Province.Suffered from knee joint hyperosteogeny (bony spur) 3 years, take we after course of treatment patient's private prosecution gone upstairs light a lot, speed is faster than in the past, walking, it is so painful also; Then mailorder the medicine of two courses of treatment once more and follow treatment, after medication two courses of treatment, patient's reaction walk away 1 hour all no problem, arthrogryposis is also less painful, goes up downstairs all without any problem.After the patient used up three courses of treatment, symptom was eliminated fully, reaches rehabilitation.
Case two is made widely known, man, 71 years old, people from Jiangsu.Double knee joint hyperosteogeny 4 years is surplus.It is painful to walk, and the stair activity joint is unable.The patient take five days posterior joints of we feel comfortable easily, after the course of treatment of taking medicine, the patient states generally to walk and has imperceptiblely ached, be to have walked howly somewhat uncomfortable, after the patient used up two courses of treatment, the stair activity articular sensation was strong, after use up three courses of treatment, recover normal.
Case three, Liu Fusheng, man, 40 years old, people from Xiamen, Fujian.Knee joint bony spur merges patella osteomalacia, and the gonalgia is a cardinal symptom when walking.The patient takes we after course of treatment, expression sensation knee joint sometimes a whole day all have nothing to do, when how walking, obvious pain is arranged, the patient continues to take medicine, and takes medicine altogether after three courses of treatment, returns to one's perfect health, and obtains satisfied curative effect.
Case four, Qian Yaozu, man, 41 years old, people from Nantong, Jiangsu Province.The difficult pain of standing up of sitting down, upward downstairs the joint is unable, and the arthralgia of going to toilet when squatting down is particularly evident, and hospital diagnosis is a knee joint hyperosteogeny, once does acupuncture in local hospital, oral drug therapy, curative effect is not good enough.Take we after course of treatment, sensory effect is very obvious, taken 3 the course of treatment medicament, knee joint is good now walks as ordinary person, upward goes downstairs, squatting down etc. has not all had symptom, reaches rehabilitation.
The specific embodiment
A kind of Chinese patent medicine that is used for the treatment of knee joint hyperosteogeny is made one day dosage by following raw material medicaments.Prescription: Olibanum 10 grams, Myrrha 12 grams, Scorpio 10 grams, Squama Manis 10 grams, Caulis Spatholobi 15 grams, Rhizoma Corydalis 12 grams, Radix Salviae Miltiorrhizae 15 grams, Herba Pyrolae 15 grams, Fructus Psoraleae 10 grams, Radix Clematidis 10 grams.
Usage: decocting, 1 dose of every day, 2 sub-services.15 days courses of treatment.
Claims (1)
1. Chinese patent medicine that is used for the treatment of knee joint hyperosteogeny, it is characterized in that the crude drug of making effective ingredient by following weight portion is: Olibanum 10 grams, Myrrha 12 grams, Scorpio 10 grams, Squama Manis 10 grams, Caulis Spatholobi 15 grams, Rhizoma Corydalis 12 grams, Radix Salviae Miltiorrhizae 15 grams, Herba Pyrolae 15 grams, Fructus Psoraleae 10 grams, Radix Clematidis 10 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101152980A CN101204436B (en) | 2007-12-17 | 2007-12-17 | Chinese patent medicine for curing hyperosteogeny in knee joint |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101152980A CN101204436B (en) | 2007-12-17 | 2007-12-17 | Chinese patent medicine for curing hyperosteogeny in knee joint |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101204436A CN101204436A (en) | 2008-06-25 |
| CN101204436B true CN101204436B (en) | 2010-06-09 |
Family
ID=39565064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007101152980A Expired - Fee Related CN101204436B (en) | 2007-12-17 | 2007-12-17 | Chinese patent medicine for curing hyperosteogeny in knee joint |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101204436B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103316133B (en) * | 2013-06-30 | 2015-06-17 | 山西省针灸研究所 | Medicine for treating lame impediment |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1150910A (en) * | 1996-04-18 | 1997-06-04 | 花茂时 | Osteophytosis pill and its compounding method |
-
2007
- 2007-12-17 CN CN2007101152980A patent/CN101204436B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1150910A (en) * | 1996-04-18 | 1997-06-04 | 花茂时 | Osteophytosis pill and its compounding method |
Non-Patent Citations (2)
| Title |
|---|
| 毛照海.骨质增生的中医药治疗现状.甘肃中医5 3.1992,5(3),45-48. |
| 毛照海.骨质增生的中医药治疗现状.甘肃中医5 3.1992,5(3),45-48. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101204436A (en) | 2008-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101297946A (en) | Plaster for activating blood and resolving stasis, dispelling wind and freeing collateral vessels and producing method thereof | |
| CN102670776B (en) | Traditional Chinese medicine composition for curing rheumatism | |
| CN101181568B (en) | Traditional chinese medicine preparation for curing osteoproliferation as well as arthrosis ache | |
| CN103191383A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
| CN103505659A (en) | Chinese proprietary medicine for treating rheumatoid arthritis | |
| CN102824500A (en) | Traditional Chinese medicine for treating protrusion of lumbar intervertebral disc and osteoproliferation | |
| CN100396321C (en) | Preparation of Chinese traditional medicine for treating hyperosteogeny | |
| CN101721651B (en) | Traditional Chinese medicine capsule for treating scapulohumeral periarthritis | |
| CN103330863A (en) | Traditional Chinese medicinal preparation for treating low back and leg pain | |
| CN101869676A (en) | Medicinal liquor for treating cold and dampness | |
| CN101204436B (en) | Chinese patent medicine for curing hyperosteogeny in knee joint | |
| CN102240351B (en) | Traditional Chinese medicine for treating Arthritis, hyperosteogeny, cervical disc herniation and cervical spondylosis | |
| CN101129697A (en) | Orally taken traditional Chinese medicine composition for treating atrophic arthritis | |
| CN103479819A (en) | Chinese herbal composition for treating rheumatoid arthritis through utilizing traditional Chinese medicinal fumigating moxibustion therapy | |
| CN101194985B (en) | Orally taken Chinese medicine composition for treating articulatio genus hyperosteogeny | |
| CN103550446B (en) | Traditional Chinese medicine composition for external use to treat rheumatoid arthritis and application of traditional Chinese medicine composition | |
| CN102441133A (en) | Traditional Chinese medicine used for treating femur head necrosis | |
| CN102018858B (en) | Traditional Chinese medicine composition for treating sprain | |
| CN1899564B (en) | External use medicine for treating hyperosteogeny and protrusion of intervertebral disc | |
| CN101041021A (en) | Chinese medicines composition took orally for treating vrain apoplexy | |
| CN1615968A (en) | Chinese medicine preparation bone setting powder for treating traumatic injury | |
| CN101204533B (en) | Yaotuhuiwei capsule combining anti-walk for prolapse of lumbar intervertebral disc | |
| CN102641348B (en) | Collateral-dredging and pain-relieving powder and preparation method thereof | |
| CN106511828A (en) | Chinese medicinal composition for treatment of acute lumbar sprain | |
| CN105194038A (en) | Medicine composition for preventing and treating Zimen traumatic injury and rheumatism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100609 Termination date: 20101217 |